WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

May 9, 2022

Weekly review: The 'very impressive' trial results of a new weight-loss drug

Daily Briefing

    What overturning Roe v. Wade could mean for health care providers, severe Covid-19 is like ageing 20 years, and more.

    50+ pounds of weight loss: The 'very impressive' trial results of a new drug (Monday, May 2)

    Eli Lilly on Thursday announced that its new experimental weight-loss drug caused clinical trial patients with obesity to lose up to 22.5% of their body weight, or more than 50 pounds.

    Supreme Court may overturn Roe v. Wade, draft opinion shows (Tuesday, May 3)

    The Supreme Court appears ready to overturn the 1973 Roe v. Wade decision, which found that the U.S. Constitution protects abortion rights, as well as the 1992 Planned Parenthood v. Casey decision, which largely reaffirmed those rights, according to a leaked draft opinion obtained by Politico.

    What overturning Roe v. Wade could mean for health care providers (Wednesday, May 4)

    As a draft opinion suggests the Supreme Court may overturn Roe v. Wade, the health care industry faces uncertain implications. Explore our interactive map of the legal landscape in the states, and learn more about the confusing patchwork of laws providers could need to navigate.

    Severe Covid-19's brain impact is like aging 20 years, study suggests (Thursday, May 5)

    Cognitive impairment resulting from severe Covid-19 is equivalent to 20 years of aging and losing 10 IQ points, according to a recent study published in eClinicalMedicine.

    Roe v. Wade's future is unclear. Are you ready to answer these questions? (Friday, May 6)

    Health care leaders have a short window—before the Supreme Court formally rules in a pending case that could overturn Roe v. Wade—to prepare for potential implications for patients and the industry. Here are the most critical questions leadership teams should be considering, according to Advisory Board's Rachel Woods and Alex Polyak.

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.